CRISPR and Genome Editing – News and Features
News
New Mechanism Discovered for DNA Recombination and Repair
A biochemistry research team at the Institute of Biological Chemistry, Academia Sinica, has discovered that the RecA family recombinases function as a new type of rotary motor proteins to repair DNA damages.
News
GATC Biotech Announces Collaboration Agreement to Develop Comprehensive DNA-Based Sepsis Diagnostic
the collaboration, which aims to develop a comprehensive DNA microarray-based diagnostic test able to detect both bacterial and fungal sepsis-triggering pathogens.
News
Polyplus-transfection to Supply RNAi Therapeutic Delivery Technology to Alnylam Pharmaceuticals
Collaboration targets improving delivery of RNAi-based therapies
News
MIT Works Toward Safer Gene Therapy
MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
News
International Stem Cell Corporation Creates Human Cornea Tissue from its Parthenote Stem Cells
Preliminary discovery holds promise to aid in therapy for blindness.
News
Cancer Research UK Selects Eden Biodesign to Develop and Manufacture two Therapeutic Candidates
Eden Biodesign to provide process development and manufacturing services for two of CR-UK’s gene therapy products for head and neck cancer.
News
MedImmune Licenses Reverse Genetics Technology to Novartis
The technology will help Novartis to support the development and construction of new vaccine strains to produce influenza vaccines.
News
One Step Closer to Transplanting Stem Cells in the Brain
Study suggests stem cells transplanted into the brains of mice generate more numerous and mature nerve cells if the brain cells called astrocytes are not activated.
News
VGX Announces Initiation of IND-enabling Toxicology Studies for Candidate DNA Vaccine Products
VGX is conducting the studies in combination with its CELLECTRA™ electroporation device and the studies will provide pre-clinical safety data for both the product candidates.
News
Treatment Permission Granted for Cancer Therapy in India
MOLOGEN’s License partner ONCO Life Sciences starts marketing activities for its cell-based gene therapy for the treatment of cancer.
Advertisement